User:Mr. Ibrahem/Etoposide

Etoposide, sold under the brand name Etopophos among others, is a chemotherapy medication used for the treatments of a number of types of cancer including testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer. It is also used for hemophagocytic lymphohistiocytosis. It is used by mouth or injection into a vein.

Side effects are very common. They can include low blood cell counts, vomiting, loss of appetite, diarrhea, hair loss, and fever. Other severe side effects include allergic reactions and low blood pressure. Use during pregnancy will likely harm the baby. Etoposide is in the topoisomerase inhibitor family of medication. It is believed to work by damaging DNA.

Etoposide was approved for medical use in the United States in 1983. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is about US$3.24 to US$5.18 per 100 mg vial. In the United Kingdom this costs the NHS about £12.15 as of 2015.